Inimmune Corp
Missoula, MT
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1121 E Broadway St #121, Missoula, MT 59802, USA
- Website
- inimmune.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $1,648,211 |
| FY2024 | $2,515,245 |
| FY2023 | $1,744,408 |
Contract awards
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Duke University | 75N93022C00053 | $613,590 | |
| The University Of Chicago | 75N93023C00044 | $1,003,536 | |
| University Of Montana | 75N93024C00024 | $519,499 | |
| University Of Montana | 75N93019C00045 | $356,336 | |
| University Of Montana | 75N93023C00047 | $233,377 |
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel synthetic TLR4 agonists | National Institute of Allergy and Infectious Diseases (NIH) | $1,004,729 | |
| Novel synthetic TLR4 agonists | National Institute of Allergy and Infectious Diseases (NIH) | $176,807 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Oregon Health & Science University | R01AI198147 | $275,341 |
Similar vendors
About the company
Inimmune Corp is a promising new biotechnology company founded by pharmaceutical industry veterans, focused on developing the next generation of vaccines and immunotherapeutics. The group has extensive expertise in synthetic and process chemistry, drug formulation, and pharmaceutical manufacturing.
Inimmune has received several prime federal contract awards from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). These include contracts for developing a synthetic AS01-like adjuvant system for influenza vaccines, a new Toll-like receptor 4 agonist treatment for allergic rhinitis under the SBIR program, adjuvant discovery for vaccines and autoimmune/allergic diseases under SBIR Phase I, and development of a Synthetic Adjuvant System under SBIR Phase II. The awards are primarily firm fixed price contracts and many have a total small business set-aside designation. Inimmune has also received several sub-contract awards from institutions like Oregon Health & Science University, Duke University, and the University of California San Diego for projects involving vaccine adjuvants, immunotherapeutics, and novel antibiotics.
Through federal grant sub-awards, Inimmune has supported research at the University of Montana on immunization against filamentous bacteriophages to prevent bacterial infection. The company has collaborated with Oregon Health & Science University on projects focused on developing novel STING pathway agonists as vaccine adjuvants and targeting IRFs for immune adjuvant enhancement of vaccine immunogenicity.
SBA capabilities narrative
Cell-based potency assays
Octet Red-based affinity measurements
Synthesis
drug formulation
Quick answers
Is Inimmune Corp registered in SAM.gov?
Yes. Inimmune Corp's SAM.gov registration is active through December 8, 2026.
What is Inimmune Corp's CAGE code?
Inimmune Corp's CAGE code is 7U1Q8, and its Unique Entity ID (UEI) is EF8AMXMGG8W5.
How much has Inimmune Corp received in federal contracts?
Federal contracts obligated $1,648,211 to Inimmune Corp in fiscal year 2025 and $5,907,864 in fiscal years 2023 through 2027.
What is Inimmune Corp's most recent federal award?
Inimmune Corp's most recent federal contract award is Development of SAS a synthetic AS01-like adjuvant system for influenza vaccines (75N93023C00042), from National Institute of Allergy and Infectious Diseases (NIH), on September 30, 2023.
On GovTribe
See Inimmune Corp's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors